Core Viewpoint - Baiaosaitu-B (02315) has seen a significant increase in stock price, reaching a new high of 37.28 HKD, following its inclusion in the Hong Kong Stock Connect program effective December 24, 2025, marking a key milestone in its capital market development [1][1][1] Group 1: Stock Performance - Baiaosaitu-B's stock rose over 6% in early trading, reaching a peak of 37.28 HKD and currently trading at 37.18 HKD with a transaction volume of 78.79 million HKD [1][1][1] Group 2: Market Announcement - The Shanghai Stock Exchange and Shenzhen Stock Exchange announced the inclusion of Baiaosaitu in the Hong Kong Stock Connect, effective December 24, 2025 [1][1][1] Group 3: Company Milestones - The successful inclusion in the Hong Kong Stock Connect is viewed as a significant milestone for the company, enhancing its capital accessibility, market recognition, and long-term investment value [1][1][1] Group 4: Analyst Insights - Galaxy Securities reported that Baiaosaitu's core technology is based on gene editing, and with the company's major investment plan entering a realization phase, significant growth in performance is anticipated [1][1][1] - The report highlights that after the company's listing on the Sci-Tech Innovation Board, it has established an A+H dual capital layout, with better liquidity in A-shares [1][1][1] - The report also notes that the Hong Kong market, as an initial listing platform, has a significant valuation discount, indicating a high margin of safety [1][1][1]
港股异动 | 百奥赛图-B(02315)涨超6%再创新高 公司已正式进入港股通 机构指千鼠万抗前景广阔